Radiopharm Theranostics Limited - Sponsored ADR RADX

Healthcare — Biotechnology

1.65 0.08 5.10% as of 25 Sep

Market cap: $24.7M
P/E: —

Follow RADX

Overview Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Dec '24	Jun '25	Dec '25	Jun '26
ROE Full definition →	+1 more TTM period Free account	—	—	—	0.00%
ROA Full definition →		—	—	—	0.00%
ROIC Full definition →		0.00%	0.00%	0.00%	0.00%
Return on Tangible Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Average Days of Receivables Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		—	—	0.00	0.00
Free Cash Flow Full definition →		—	—	(68.16)	(88.91)
Piotroski F-Score Full definition →		0.00	0.00	0.00	0.00
Other line items
Cash ROIC Full definition →		0.00%	0.00%	(122.94%)	(495.06%)
Accounts Receivable Turnover Full definition →		—	—	—	0.00
Accounts Payable Turnover Full definition →		—	—	—	0.00
Average Days of Payables Full definition →		0.00	0.00	0.00	0.00
Operating CF/Net income Full definition →		—	—	0.00	0.00
Depreciation/Fixed assets Full definition →		0.00	—	0.00	—
Operating CF per Share Full definition →		—	—	0.00	0.00

Fold the line items

Columns are period end dates